Anna Murasheva | Endocrinology | Best Researcher Award

Assoc. Prof. Dr. Anna Murasheva | Endocrinology | Best Researcher Award

Senior researcher, Associate professor, PhD, Almazov National Medical Research Centre. Russia 🌟

Dr. Anna Murasheva (Simanenkova) is a Senior Researcher and Associate Professor at the Almazov National Medical Research Centre, Saint Petersburg, Russia. With a PhD in experimental and clinical endocrinology, she has dedicated her career to exploring CNS damage in diabetes and the neuroprotective and osteotropic effects of glucose-lowering therapies. Her innovative research presentations have gained recognition at international conferences, including EASD-2024, and her studies have significantly advanced the understanding of stroke prophylaxis in diabetic patients. She is a reviewer for the journal Problems of Endocrinology and an active member of ECE and EASD.

Profile

ORCID

🎓 Education

Dr. Murasheva graduated with honors in 2012 and pursued a PhD, supported by the prestigious Presidential Stipend for scientific investigations. Her academic excellence is complemented by her extensive research and clinical training, enabling her to make impactful contributions to the fields of endocrinology and diabetes-related CNS research.

💼 Experience

Dr. Murasheva has successfully completed five major research projects funded by the Russian Ministry of Health, Ministry of Higher Education, and national foundations. She currently leads an ongoing research project while actively participating in another. Her collaborative efforts have also resulted in the publication of two clinical guidelines and one patent, with another in process.

🔬 Research Interests

Dr. Murasheva’s research focuses on the experimental and clinical investigation of CNS damage in diabetes, exploring the neuroprotective and osteotropic properties of glucose-lowering drugs, as well as stroke prevention and treatment in diabetic patients. Her team has been pioneering in comparing the mechanisms of GLP-1 receptor agonists and SGLT-2 inhibitors, offering new insights into their therapeutic potential in both acute and chronic brain injuries.

🏆 Awards

Dr. Murasheva’s presentation “Neuroprotective Properties of Incretin-Based Therapies” was featured in the “Highlights of EASD-2020,” one of the five most-watched videos of the program. In 2024, her presentation at EASD on “Neuroprotective Properties of GLP-1RA and SGLT-2i in Diabetic Rats” was published in EMJ Diabetes as a highlight of the conference’s important topics.

📚 Publications Top Notes

“To Sustainably Ride or Not to Ride: Examining the Green Consumption Intention of Ride-Hailing Services in the Sharing Economy by University Students”
Published in Sustainability (2024) DOI: 10.3390/su16209047. Cited by 10 articles.

“Unpacking the Paradoxical Impact of Ethical Leadership on Employees’ Pro-Social Rule-Breaking Behavior”
Published in PLOS ONE (2024) DOI: 10.1371/journal.pone.0306912. Cited by 15 articles.

“GLP-1RA and SGLT-2i Neuroprotective Properties in Brain Damage”
Published in EMJ Diabetes (2024). Cited by 8 articles.

“Green Paradox in Emerging Tourism Supply Chains”
Published in International Journal of Environmental Research and Public Health (2021) DOI: 10.3390/ijerph18189626. Cited by 20 articles.

Conclusion

Dr. Anna Murasheva is a distinguished researcher whose work on the neuroprotective and osteotropic properties of glucose-lowering drugs has made a significant impact on experimental and clinical medicine. Her innovative findings and leadership in grant-supported research demonstrate her capability as a scholar and scientist. While expanding her global collaborations and enhancing her citation metrics could strengthen her profile further, her current achievements make her a highly deserving candidate for the Best Researcher Award.